Synapse - Eileen O'Reilly

Results (803)

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): A randomised, open-label, phase 3 trial

Journal Article

Wainberg, Z. A.; Melisi, D.; Macarulla, T.; Pazo Cid, R.; Chandana, S. R.; De La Fouchardière, C.; Dean, A.; Kiss, I.; Lee, W. J.; Goetze, T. O.; more...
Lancet (2023)

Fulltext@MSK | Save

Metastatic well differentiated serotonin-producing pancreatic neuroendocrine tumor with carcinoid heart disease: A case report

Journal Article

Kudelka, M. R.; Abou-Alfa, G. K.; O’Reilly, E. M.; Foote, M. B.; Sirohi, B.; Elias, R.; Shamseddine, A.; Paroder, V.; Moussa, A. M.; Cohen, P.; more...
Journal of Gastrointestinal Oncology (2023)

Fulltext@MSK | Save

Genomic biomarkers associated with response to induction chemotherapy in patients with localized pancreatic ductal adenocarcinoma

Meeting Abstract

Tao, A. J.; Ecker, B. L.; Janssen, Q.; Balachandran, V. P.; D'Angelica, M. I.; Drebin, J. A.; Brennan, M. F.; Kingham, T. P.; Soares, K. C.; Gonen, M.; more...
Annals of Surgical Oncology (2023)

Fulltext@MSK | Save

Liposomal irinotecan + 5-fluorouracil/leucovorin + oxaliplatin (NALIRIFOX) versus nab-paclitaxel + gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma: Sensitivity analysis of survival from the NAPOLI 3 trial

Meeting Abstract

Wainberg, Z.; Melisi, D.; Macarulla, T.; Cid, R. P.; Chandana, S.; de la Fouchardiere, C.; Dean, A.; Kiss, I.; Lee, W.; Goetze, T.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save

Outcomes in advanced hepatocellular carcinoma (HCC) patients (pts) treated with immune checkpoint inhibitors (ICI)

Meeting Abstract

Cowzer, D.; Capanu, M.; Keane, F.; Khalil, D.; Shia, J.; Do, R.; Chou, J.; Walch, H.; El Dika, I.; Yaqubie, A.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save

Patients (pts) with advanced hepatocellular carcinoma (HCC) with long-term response to immune checkpoint inhibitor (ICI) therapy

Meeting Abstract

Keane, F.; Cowzer, D.; Khalil, D.; Shia, J.; Do, R.; Folorunso, S.; El Dika, I.; Yaqubie, A.; Kim, T.; O'Reilly, E.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save

NALIRIFOX (iposomal irinotecan + 5-fluorouracil/feucovorin + oxaliplatin) versus FOLFOX [5-fluorouracil/leucovorin + oxaliplatin] as first-line treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC): Real-world comparative overall survival

Meeting Abstract

O'Reilly, E.; Li, J.; DerSarkissian, M.; Chang, R.; Cheng, M.; Yu, L.; Rane, D.; Zhang, L.; Xiao, Z.; Benzaghou, F.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save

Preoperative treatment of locally advanced rectal cancer

Journal Article

Schrag, D.; Qian, S.; Weiser, M. R.; Gollub, M. J.; Saltz, L. B.; Musher, B. L.; Goldberg, J.; Al Baghdadi, T.; Goodman, K. A.; McWilliams, R. R.; more...
New England Journal of Medicine (2023)

Fulltext@MSK | Save

Alliance A022101: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer – Evaluating radiation, ablation and surgery (ERASur)

Meeting Abstract

Romesser, P. B.; Miller, E. D.; Shi, Q.; Dixon, J. G.; Gholami, S.; White, S.; Wu, C.; Goulet, C. C.; Jee, K. W.; Wright, C. L.; more...
International Journal of Radiation Oncology, Biology, Physics (2023)

Fulltext@MSK | Save

Patient-reported adverse events during neoadjuvant therapy in a phase 2 borderline resectable pancreatic cancer clinical trial (Alliance A021501)

Conference Paper

Snyder, R. A.; Dueck, A. C.; Fruth, B.; Shi, Q.; Hubbard, J. M.; Herman, J. M.; O'Reilly, E. M.; Katz, M. H. G.
Lippincott Williams & Wilkins (2023)

Fulltext@MSK | Save